Search This Blog

Wednesday, August 5, 2020

ResMed EPS beats by $0.25, beats on revenue

ResMed (NYSE:RMD): Q4 Non-GAAP EPS of $1.33 beats by $0.25; GAAP EPS of $1.22 beats by $0.20.
Revenue of $770.3M (+9.3% Y/Y) beats by $15.29M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)